Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivo
出版年份 2013 全文链接
标题
Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivo
作者
关键词
-
出版物
Scientific Reports
Volume 3, Issue 1, Pages -
出版商
Springer Nature
发表日期
2013-08-21
DOI
10.1038/srep02459
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Down-regulation of miR-21 Induces Differentiation of Chemoresistant Colon Cancer Cells and Enhances Susceptibility to Therapeutic Regimens
- (2014) Yingjie Yu et al. Translational Oncology
- Moving towards molecular-guided treatments: erlotinib and clinical outcomes in non-small-cell lung cancer patients
- (2013) Mariacarmela Santarpia et al. Future Oncology
- Epigenetic modulation of the miR-200 family is associated with transition to a breast cancer stem-cell-like state
- (2013) Y.-Y. Lim et al. JOURNAL OF CELL SCIENCE
- N-Cadherin Expression Is Associated with Acquisition of EMT Phenotype and with Enhanced Invasion in Erlotinib-Resistant Lung Cancer Cell Lines
- (2013) Xiaoju Zhang et al. PLoS One
- Reduced Expression of miR-200 Family Members Contributes to Antiestrogen Resistance in LY2 Human Breast Cancer Cells
- (2013) Tissa T. Manavalan et al. PLoS One
- Reduced miR-31 and let-7 maintain the balance between differentiation and quiescence in lung cancer stem-like side population cells
- (2012) Shen Hua et al. BIOMEDICINE & PHARMACOTHERAPY
- MicroRNA control of epithelial–mesenchymal transition and metastasis
- (2012) Jinsong Zhang et al. CANCER AND METASTASIS REVIEWS
- Primary and Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer: An Update
- (2012) Ayodele Ayoola et al. CANCER INVESTIGATION
- MiR-21 regulates epithelial-mesenchymal transition phenotype and hypoxia-inducible factor-1α expression in third-sphere forming breast cancer stem cell-like cells
- (2012) Mingli Han et al. CANCER SCIENCE
- An Epithelial-Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance
- (2012) L. A. Byers et al. CLINICAL CANCER RESEARCH
- Recent understanding of the molecular mechanisms for the efficacy and resistance of EGF receptor-specific tyrosine kinase inhibitors in non-small cell lung cancer
- (2012) Asuka Nakata et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- ZEB/miR-200 feedback loop: At the crossroads of signal transduction in cancer
- (2012) Louise Hill et al. INTERNATIONAL JOURNAL OF CANCER
- A sensitive LC–MS/MS assay for the simultaneous analysis of the major active components of silymarin in human plasma
- (2012) Bryan J. Brinda et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
- (2012) Rafael Rosell et al. LANCET ONCOLOGY
- Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
- (2012) Zhenfeng Zhang et al. NATURE GENETICS
- Antagonism of miR-21 Reverses Epithelial-Mesenchymal Transition and Cancer Stem Cell Phenotype through AKT/ERK1/2 Inactivation by Targeting PTEN
- (2012) Mingli Han et al. PLoS One
- Loss of Activating EGFR Mutant Gene Contributes to Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in Lung Cancer Cells
- (2012) Keisuke Tabara et al. PLoS One
- Resveratrol Reduces Prostate Cancer Growth and Metastasis by Inhibiting the Akt/MicroRNA-21 Pathway
- (2012) Sandeep Sheth et al. PLoS One
- EMT and induction of miR-21 mediate metastasis development in Trp53-deficient tumours
- (2012) Olga Bornachea et al. Scientific Reports
- Epithelial Mesenchymal Transition in Drug Resistance and Metastasis of Lung Cancer
- (2012) Fariz Nurwidya et al. Cancer Research and Treatment
- Mechanistic insights into the role of microRNAs in cancer: influence of nutrient crosstalk
- (2012) Manasvi S. Shah et al. Frontiers in Genetics
- MicroRNAs: critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progression
- (2011) Marc D. Bullock et al. BIOLOGY OF THE CELL
- A microRNA gene expression signature predicts response to erlotinib in epithelial cancer cell lines and targets EMT
- (2011) J L Bryant et al. BRITISH JOURNAL OF CANCER
- RETRACTED: Notch-1 induces epithelial–mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells
- (2011) Bin Bao et al. CANCER LETTERS
- Role of E-cadherin in Antimigratory and Antiinvasive Efficacy of Silibinin in Prostate Cancer Cells
- (2011) G. Deep et al. Cancer Prevention Research
- Identification of Silymarin Constituents: An Improved HPLC–MS Method
- (2011) Ákos Kuki et al. CHROMATOGRAPHIA
- A 5-MicroRNA Signature for Lung Squamous Cell Carcinoma Diagnosis and hsa-miR-31 for Prognosis
- (2011) X. Tan et al. CLINICAL CANCER RESEARCH
- Epithelial to Mesenchymal Transition in an Epidermal Growth Factor Receptor-Mutant Lung Cancer Cell Line with Acquired Resistance to Erlotinib
- (2011) Kenichi Suda et al. Journal of Thoracic Oncology
- Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells
- (2011) Mingli Han et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
- (2011) L. V. Sequist et al. Science Translational Medicine
- Slug Confers Resistance to the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
- (2010) Tzu-Hua Chang et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Predictive biomarkers in the management of EGFR mutant lung cancer
- (2010) Rafael Rosell et al. Annals of the New York Academy of Sciences
- Acquired resistance of lung adenocarcinoma to EGFR-tyrosine kinase inhibitors gefitinib and erlotinib
- (2010) Yan Xu et al. CANCER BIOLOGY & THERAPY
- Gemcitabine Sensitivity Can Be Induced in Pancreatic Cancer Cells through Modulation of miR-200 and miR-21 Expression by Curcumin or Its Analogue CDF
- (2010) Shadan Ali et al. CANCER RESEARCH
- Non-small-cell lung cancer harbouring mutations in the EGFR kinase domain
- (2010) Rafael Rosell et al. Clinical & Translational Oncology
- Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance
- (2010) Zhiwei Wang et al. DRUG RESISTANCE UPDATES
- Implication of microRNAs in drug resistance for designing novel cancer therapy
- (2010) Fazlul H. Sarkar et al. DRUG RESISTANCE UPDATES
- The ZEB/miR-200 feedback loop—a motor of cellular plasticity in development and cancer?
- (2010) Simone Brabletz et al. EMBO REPORTS
- miR-21 and miR-31 Converge on TIAM1 to Regulate Migration and Invasion of Colon Carcinoma Cells
- (2010) Charisa L. Cottonham et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors
- (2010) Xi Liu et al. JOURNAL OF CLINICAL INVESTIGATION
- microRNAs and EMT in Mammary Cells and Breast Cancer
- (2010) Josephine A. Wright et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Rapid separation and characterization of active flavonolignans of Silybum marianum by ultra-performance liquid chromatography coupled with electrospray tandem mass spectrometry
- (2010) Kuiwu Wang et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Clinical and molecular evidences of epithelial to mesenchymal transition in acquired resistance to EGFR-TKIs
- (2010) Jin-Haeng Chung et al. LUNG CANCER
- Combined Treatment with Silibinin and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Overcomes Drug Resistance Caused by T790M Mutation
- (2010) J. K. Rho et al. MOLECULAR CANCER THERAPEUTICS
- Wnt signaling may be activated in a subset of Peutz-Jeghers syndrome polyps closely correlating to LKB1 expression
- (2010) Wu ONCOLOGY REPORTS
- Regulation of microRNAs by Natural Agents: An Emerging Field in Chemoprevention and Chemotherapy Research
- (2010) Yiwei Li et al. PHARMACEUTICAL RESEARCH
- Restoration of Altered MicroRNA Expression in the Ischemic Heart with Resveratrol
- (2010) Partha Mukhopadhyay et al. PLoS One
- Up-regulation of miR-200 and let-7 by Natural Agents Leads to the Reversal of Epithelial-to-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer Cells
- (2009) Y. Li et al. CANCER RESEARCH
- miR-200 Expression Regulates Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Reverses Resistance to Epidermal Growth Factor Receptor Therapy
- (2009) L. Adam et al. CLINICAL CANCER RESEARCH
- Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancers Dependent on the Epidermal Growth Factor Receptor Pathway
- (2009) Kim-Son H. Nguyen et al. Clinical Lung Cancer
- MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer
- (2009) P. Olson et al. GENES & DEVELOPMENT
- The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
- (2009) Ulrich Wellner et al. NATURE CELL BIOLOGY
- Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer
- (2009) Rafael Rosell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors
- (2009) A F Gazdar ONCOGENE
- Epithelial-to-Mesenchymal Transition and Integrin-Linked Kinase Mediate Sensitivity to Epidermal Growth Factor Receptor Inhibition in Human Hepatoma Cells
- (2008) B. C. Fuchs et al. CANCER RESEARCH
- Silibinin Inhibits Established Prostate Tumor Growth, Progression, Invasion, and Metastasis and Suppresses Tumor Angiogenesis and Epithelial-Mesenchymal Transition in Transgenic Adenocarcinoma of the Mouse Prostate Model Mice
- (2008) R. P. Singh et al. CLINICAL CANCER RESEARCH
- A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells
- (2008) Ulrike Burk et al. EMBO REPORTS
- Dose translation from animal to human studies revisited
- (2007) Shannon Reagan-Shaw et al. FASEB JOURNAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More